Life ScienceCompany
Agilis Biotherapeutics Ownership
Who owns Agilis Biotherapeutics?
Agilis Biotherapeutics is owned by PTC Therapeutics. It was acquired on July 19, 2018.
Agilis Biotherapeutics Business Overview
Where is Agilis Biotherapeutics headquartered?
Agilis Biotherapeutics is headquartered in Cambridge, Massachusetts.
What sector is Agilis Biotherapeutics in?
Agilis Biotherapeutics is a life science company.
When was Agilis Biotherapeutics founded?
Agilis Biotherapeutics was founded in 2013.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.